证券记录 · 已归档季度
AMRX
Amneal Pharmaceuticals, Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
15被追踪持有人
-1Δ持有人
52.63M持有股份
$425.79M报告持仓市值
+0新建仓位
−1清仓
动量输入（同类管理人）：
持有人广度 -6.2% ·
股份流向 +3.0% ·
净新建仓位 -6.7%
— 公式
集中积累 — 持股数量上升但持有人减少
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 101 | -4 | 106.56M | $1.84B | +7 | −10 |
| Q1 2026 | 107 | -1 | 100.53M | $1.25B | +9 | −11 |
| Q4 2025 | 109 | 0 | 106.30M | $1.34B | +1 | — |
| Q3 2025 | 18 | 0 | 61.16M | $612.26M | — | — |
| Q2 2025 | 15 | -1 | 52.63M | $425.79M | — | −1 |
| Q1 2025 | 13 | +3 | 21.14M | $177.14M | +3 | — |
| Q4 2024 | 10 | -1 | 20.64M | $163.48M | — | −1 |
| Q3 2024 | 10 | 0 | 16.87M | $140.36M | +2 | −2 |
| Q2 2024 | 10 | — | 16.56M | $105.19M | — | — |
持有人 · Q2 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (被动) | 17.55M | — | $141.99M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | The Vanguard Group ✦ (被动) | 17.55M | — | $141.99M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | The Vanguard Group ✦ (被动) | 17.55M | — | $141.99M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | The Vanguard Group ✦ (被动) | 17.55M | — | $141.99M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | The Vanguard Group ✦ (被动) | 17.55M | — | $141.99M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (被动) | 12.13M | — | $98.14M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (被动) | 12.13M | — | $98.14M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (被动) | 12.13M | — | $98.14M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (被动) | 12.13M | — | $98.14M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (被动) | 12.13M | — | $98.14M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (被动) | 12.13M | — | $98.14M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | BlackRock ✦ (被动) | 12.13M | — | $98.14M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | BlackRock ✦ (被动) | 12.13M | — | $98.14M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | BlackRock ✦ (被动) | 12.13M | — | $98.14M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | BlackRock ✦ (被动) | 12.13M | — | $98.14M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | BlackRock ✦ (被动) | 12.13M | — | $98.14M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | BlackRock ✦ (被动) | 12.13M | — | $98.14M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | BlackRock ✦ (被动) | 12.13M | — | $98.14M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | BlackRock ✦ (被动) | 12.13M | — | $98.14M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | Citadel Advisors ✦ | 5.62M | -24.9% | $45.50M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 21 | Citadel Advisors ✦ | 5.62M | -24.9% | $45.50M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 22 | Millennium Management ✦ | 5.04M | +141.6% | $40.80M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 23 | State Street Global Advisors ✦ (被动) | 3.92M | +6.1% | $31.68M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 24 | Geode Capital Management ✦ (被动) | 3.76M | -1.7% | $30.41M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 25 | Geode Capital Management ✦ (被动) | 3.76M | -1.7% | $30.41M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 26 | Arrowstreet Capital ✦ | 1.70M | -5.4% | $13.73M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 27 | AQR Capital Management ✦ | 1.02M | +36.7% | $8.24M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 28 | AQR Capital Management ✦ | 1.02M | +36.7% | $8.24M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 29 | AQR Capital Management ✦ | 1.02M | +36.7% | $8.24M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 30 | AQR Capital Management ✦ | 1.02M | +36.7% | $8.24M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 31 | AQR Capital Management ✦ | 1.02M | +36.7% | $8.24M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 32 | D. E. Shaw & Co. ✦ | 923.64K | +5732.6% | $7.47M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 33 | D. E. Shaw & Co. ✦ | 923.64K | +5732.6% | $7.47M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 34 | Renaissance Technologies ✦ | 428.00K | -31.5% | $3.46M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 35 | Fidelity (FMR) ✦ | 263.69K | — | $2.13M | 0.0% | n/c | 1 | SEC ↗ |
| 36 | Fidelity (FMR) ✦ | 263.69K | — | $2.13M | 0.0% | n/c | 1 | SEC ↗ |
| 37 | T. Rowe Price ✦ | 130.65K | +3.1% | $1.06M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 38 | Wellington Management ✦ | 65.62K | -6.3% | $530,841 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 39 | Wellington Management ✦ | 65.62K | -6.3% | $530,841 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 40 | Wellington Management ✦ | 65.62K | -6.3% | $530,841 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 41 | Wellington Management ✦ | 65.62K | -6.3% | $530,841 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 42 | Gotham Asset Management ✦ | 60.20K | +14.3% | $487,042 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 43 | Two Sigma Investments ✦ | 17.75K | -89.4% | $143,557 | 0.0% | ▼ Trim | 2 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| Point72 Asset Management | $3.74M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 314 持有人, 158.91M 股份, $1.92B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Aug 13
Kiely John
Director · 50.00K 股 · $882,000
Aug 12
Shah Nikita
Officer · 146.40K 股 · $2.56M
Aug 12
Daly Jason B.
Officer · 210.00K 股 · $3.65M
Aug 11
Daly Jason B.
Officer · 6.61K 股 · $117,050
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
Aug 12
SC 13D/A — Patel Tushar Bhikhubhai
17.6% 占股份类别 · 查看 SEC 原始申报文件 ↗
Aug 12
SC 13D/A — Patel Chirag K.
8.4% 占股份类别 · 查看 SEC 原始申报文件 ↗
Aug 12
SC 13D/A — Patel Chintu
9.4% 占股份类别 · 查看 SEC 原始申报文件 ↗
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2025 ·
方法论 ·
通过API获取此数据